¤½¥ÁÂI¹ïÂI¡G95½a°êÀò­ã¥é»s·s«a¤fªAÃÄ

[2021.12.13] µoªí
¬ü°êÃļt½÷·ç¦P·N¦b§K°£±M§Q¶O¤U¡A¤¹³\95­Óµo®i¤¤°ê®a¥Í²£¨Ã¥X°â¨ä§Ü·s«a¯f¬r¤fªAÃÄPaxlovid¡C¹Ï¬°½÷·ç©ó¼w°ê¥±µÜ³ùªº¼t©Ð¥¿¦b¥Í²£¸ÓÃĪ«¡C¡]¸ô³zªÀ¡^
¤H¥Á¬Ì­]Áp·ù¦h¦¸¤Ï¹ï¥þ²y¬Ì­]¤À°t¤£¤½¡C2021¦~3¤ë¡A¤H¥Á¬Ì­]Áp·ù¦b¬ü°ê²ö¼w¯ÇÁ`³¡¥~§Üij¡C¡]¸ô³zªÀ¡^

¡i©ú³ø±M°T¡j·s»D¼¼­n

¬ü°êÃļt½÷·ç2021¦~11¤ëªì¤½¥¬ºX¤U·s«¬«aª¬¯f¬r¤fªAÃÄPaxlovidªºÁ{þH¸ÕÅç¼Æ¾Ú¡AÅã¥Ü±wªÌ¦bµo¯f«á3¤Ñ¤ºªAÃÄ¡A¥i±N¤J°|©Î¦º¤`­·ÀI¤j´î89%¡C½÷·ç11¤ë16¤é«Å¥¬¡A»PÁp¦X°ê¤ä«ùªº«D¦È§Q²Õ´¡uÃÄ«~±M§QÁp·ù¡v(Medicines Patent Pool)¹F¦¨¨óij¡A±N¤¹³\95­Óµo®i¤¤°ê®a¥Í²£¨Ã¥X°âPaxlovid¡C

²[¥þ²y53%¤H¤f ¤£¯Ç¤¤«X

¨óij²[»\ªº°ê®a¤j¦h¦ì©ó«D¬w¤Î¨È¬w¡A¦û¥þ²y¤H¤f53%¡A¥]¬A§C¦¬¤J¤Î¤¤§C¦¬¤J°ê®a¡B­Ó§O¦b¼»«¢©Ô¥H«n«D¬wªº¤¤°ª¦¬¤J°ê®a¡A¥H¤Î¤@¨Ç¦b¹L¥h5¦~¹L´ç¦Ü¤¤°ª¦¬¤Jªº°ê®a¡C³¡¤À³Q¥@¬É»È¦æ©w¬°¤¤°ª¦¬¤Jªº°ê®a«h¤£¦b¨óij¤º¡A¦p¤¤°ê¡B«Xù´µ¡B¤Ú¦è¡B¥j¤Ú¡B¥ì©Ô§J¡B§Q¤ñ¨È©M¤ú¶R¥[¡C½÷·ç±N¤¹³\ÃÄ«~±M§QÁp·ù¦V¦X¸ê®æ¥é»sÃÄ»s³y°Ó§å¥X³\¥i¦Û¦æ¥Í²£Paxlovid¡A¤£·|¹ï¦b§C¦¬¤J°ê®aªº¾P°â¼x¦¬±M§Q¶O¡C¦Ü©ó¨óij¤ºªº¨ä¥L°ê®a¡A¥u­n¥@½Ã¤´±N·s«a¯f¬r¦C¬°¡u°ê»Ú¤½¦@½Ã¥Íºò«æ¨Æ¥ó¡v(PHEIC)¡A½÷·ç¥ç¤£·|¦¬¶O¡C

ÃÄ«~±M§QÁp·ù°õ¦æ¸³¨Æ¤àº¸(Charles Gore)«ü¥X¡A²{®ÉÂå¥Í¶·¨Ì¿à©ù¶Q¥B³q±`»Ý­nª`®gªºÃĪ«¡A¨Ò¦p·ç¼w¦è­³(Remdesivir)¡A¦ÓPaxlovid®e©öªA¥Î¡A¾ã­ÓÀøµ{¥u»Ý5¤Ñ¡A¥B¥Í²£¦¨¥»¸û§C¡A¹ï¤¤¡B§C¦¬¤J°ê®a¤×¨ä­«­n¡AÁp·ù¤w±µ¨ì20¦h¶¡¤½¥qªí¥Ü¦³·N¨ú±o³\¥i¡A©Î¯à©ó2022¦~²Ä¤@©u«×¶}©l¥Í²£¡C

µL°ê¬ÉÂå¥Í(MSF)´£­ÒÂåÀø¥­µ¥¦æ°Êªº¤Ú¦è¥Nªí¥d¥Ë²¤(Felipe Carvalho)§åµû¡A¤Ú¦èÁö¬O¤¤°ª¦¬¤J°ê¡A¦ý¦³¥|¤À¤§¤T¤H¨Ì¿à¤½¥ßÂåÀø¨t²Î¡A«Ü¤Ö¤H¯à­t¾á©ù¶QªºªvÀø¶O¥Î¡A¸Ó°ê¬O·s«a¯f¬r¦º¤`¼Æ¦r³Ì°ªªº°ê®a¤§¤@¡C¸Ó²Õ´¥ç¦³±M®a½èºÃ¡A¨óij¨S¯Ç¤Jªü®Ú§Ê©M¤¤°êµ¥¤w¦³¯à¤O¥Í²£¥é»sÃĪº°ê®a¡C

«ü¬Ì­]¥Í²£½ÆÂø©ö¿ù Ãļt©ÚºM±M§Q

¦³§O¹ï·s«a¬Ì­]ªº¨úºA¡A¤µ¦¸¬O½÷·ç­º¦¸¦P·N¤À¨É»P·s«a¯f¬r¬ÛÃöªºÂåÀø²£«~§Þ³N¡C½÷·ç»P¦X§@¥ë¦ñBioNTech¤Ï¹ï¨ú®ø·s«a¬Ì­]±M§Q¡A«ü¬Ì­]¥Í²£¹Lµ{»·¸û¤fªAÃĽÆÂø¡A²Ä¤T¤è»s³y°Ó¦³¥i¯à¥X¿ù¡A·l®`¤½²³«H¤ß¡A¥L­Ì¥D±i´£°ª¦Û®a²£¶q¡A¦bµo®i¤¤°ê®a¥H¸û§C»ù®æ¥X°â¬Ì­]¡ABioNTech¥ç­p¹º¦b«D¬w«Ø¼t¡C¥Ø«e½÷·ç¤w¦V¥þ²y¨ÑÀ³¹O20»õ¾¯¬Ì­]¡A¦ý¥u¦³¤£¨¬1.7»õ¾¯¹B©¹µo®i¤¤°ê®a¡C

­»´äÂå°|Ãľ¯®v¾Ç·|·|ªø±Z«T©ú«ü¥X¡A¥Ø«e¤£¤Ö½T¶EªÌ¯f±¡»´·L¡A¬Æ¦ÜµL¯f¼x¡A·s«a¤fªAÃĪ«©Î¥i¥O¨S°ª¦M¦]¯Àªº½T¶EªÌ©~®a¹jÂ÷¡A§UÓV½w¯fþHÀ£¤O¡C

¡½ ÃĪ«±M§Q¢ß¡®¢Ï

¢ß¡G¤°»ò¬OÃĪ«±M§Q¡H

¢Ï¡G¦]¬ã»s·sÃįA¤Î¥¨ÃB§ë¸ê¡AÃĪ«±M§Qªº­ì·N¬°«OÅ@·sÃĪºª¾ÃѲ£Åv¡C¥@¬É¶T©ö²Õ´©ó1994¦~­q¥ß¡m»P¶T©ö¦³Ãöªºª¾ÃѲ£Åv¨óij¡n(TRIPS)¡A­n¨D¦¨­û°ê¨î­qªk«ß«O»Ùª¾ÃѲ£Åv¡A¥Íª«¬ì§Þ©MÃĪ«±M§QÅvÄݨä«O»Ù½d³ò¡C®Ú¾Ú¨ó©w¡A¬ãµoÃļt¥i±N»sÃĹLµ{©M¦¨«~¥Ó½Ð±M§Q¡A´Á­­¬°20¦~¡C±M§Q´Á­­¹L«áÃļt¶·¤½¶}°t¤è¡A¨ä¥LÃļt¥i¨Ì°t¤è°t»sÃĪ«¡A§Y¥é»sÃÄ¡C

¢ß¡GÃĪ«±M§QÅv¦³¤°»ò§@¥Î¡H

¢Ï¡GÃĪ«±M§QÅv«O»Ù­ì¬ãµoÃļt¨É¦³¿W®a¥Í²£Åv¡A¸T¤î¨ä¥LÃļt½Æ»s©Î¥é»s¡A¦P®É¸T¤î¥@¶T¦¨­û°ê¶i¤f¥é»sÃĪ«¡F¦pµo²{¥é»sÃĪ«¡AÃļt¥i¥H´£¥X¶D³^¡A¸T¤î«IÅv¦æ¬°¡C

¡D¥þ²y¦U¤j¬w¬Ì­]±µºØ²v(%)(¹Ï)

¡»ª¾ÃѼW¯q

¤HÅv²Õ´¡G3ÃÄ¥ø¤é§¡ÁȹO7»õ

¥Ñ¦h­Ó°ê»Ú¤HÅv©M·Oµ½²Õ´²Õ¦¨ªº¡u¤H¥Á¬Ì­]Áp·ù¡v(People's Vaccine Alliance)2021¦~11¤ëµoªí³ø§i¡A§åµû¬ü°ê½÷·ç¡B¼w°êBioNTech©M¬ü°ê²ö¼w¯ÇÃļt¡A±N¤j³¡¤À·s«a¬Ì­]½æµ¹´I¸Î°ê®a¡A«o¹ï§C¦¬¤J°ê®a±ó¦Ó¤£ÅU¡C³ø§i®Ú¾Ú3®a¤½¥qªº°]°È³ø§i¦ôºâ¡A¥¦­Ì2021¦~µ|«e¬Õ§QÁ`­p340»õ¬ü¤¸(¬ù2651»õ´ä¤¸)¡A´«ºâ«á¬Û·í©ó¨C¤Ñ¬ù9350¸U¬ü¤¸(¬ù7.3»õ´ä¤¸)¡C

§åÀòª`¸ê¹O600»õ«oÂ÷±ó½a°ê

¤H¥Á¬Ì­]Áp·ùªí¥Ü¡A½÷·ç©MBioNTech¤w¥I¹B¥æµ¹§C¦¬¤J°ê®aªº¬Ì­]¤£¨ìÁ`¼Æ1%¡A²ö¼w¯Ç§ó¥u¦³0.2%¡C¤H¥Á¬Ì­]Áp·ùªí¥Ü¡A¾¨ºÞ½÷·ç¡BBioNTech©M²ö¼w¯ÇÀò±o¤½¦@¸êª÷¶W¹L80»õ¬ü¤¸(¹O624»õ´ä¤¸)¡A¥L­Ì¤@ª½©Úµ´³z¹L¥@½Ã±N¬Ì­]§Þ³NÂಾµ¹¤¤§C¦¬¤J°ê®aªº¼t°Ó¨ó§U¥Í²£¡A¥H´£°ª¥þ²y¨ÑÀ³¶q©MÀ£§C»ù®æ¡C

¡D¥D­n¬ÛÃö½ÒÃD¡G¤½¦@½Ã¥Í»P¤HÃþ°·±d¡D

¡´¼ÒÀÀ¸ÕÃD

(1) ¤U¦C­þ¤@­Ó²Õ´ÄݬF©²¶¡°ê»Ú²Õ´¡H (1¤À)

A. ¼Ö¬I·|

B. µL°ê¬ÉÂå¥Í

C. °ê»Ú¯S³j²Õ´

D. ¥@¬É½Ã¥Í²Õ´

(2) ®Ú¾Ú¸ê®Æ¡A¤U¦C­þ¶µ¦³ÃöÃĪ«±M§Qªº´y­z¨Ã¤£¥¿½T¡H (1¤À)

(1)ÃĪ«±M§QÅv¥Ã¤[¦³®Ä

(2)Ãļt»Ý¥ý¤½¶}·sÃÄ°t¤è¤~¥i¨É¦³ÃĪ«±M§QÅv

(3)¦pµo²{¥é»sÃĪ«¡A±M§QÅv«ù¦³¤H¥i´£¥X¶D³^

A. ¥u¦³(1)

B. ¥u¦³(3)

C. (1)»P(2)

D.(1)¡B(2)»P(3)

(3) ´y­z¡u¥þ²y¦U¤j¬w¬Ì­]±µºØ²v¡v¹Ïªí¯S¼x¡C (4¤À)

(4a) ®Ú¾Ú¸ê®Æ¡A«ü¥X¤Î»¡©ú¤@¶µ¥i¯à¾É­P¡u¬Ì­]µS¿Ý¡v¥X²{ªº­ì¦]¡C (2¤À)

(4b) »¡©ú·s«a¬Ì­]¹ïºû«ù¤½¦@½Ã¥Íªº­«­n¡C (3¤À)

[´¼¾Ç¤½¥Á ²Ä14´Á]

§ó¦h±Ð¨|
ª¾ÃÑÄ_®w¡Gªv¤ô¤uµ{
¡i©ú³ø±M°T¡j·s»D¼¼­n 2021¦~7¤ëªe«n¼É«B¾É­P¤ô¨a¡A¬Ù·|¾G¦{¥«¤ô®ûÄY­«¡A¥þ¬Ù³Ì¤Ö1481¸U¤H¨ü¨a¡B302¤H¦º¤`¤Î50¤H¥¢ÂÜ¡C10¤ë¤s... ¸Ô±¡
¤j¶}²´¬É¡G°ê»Ú¯à·½¸p¡]IEA¡^
¡i©ú³ø±M°T¡j¹q¤O¡B¨T¨®¿U®Æµ¥§¡¨ú¦Û¥Ûªo¡B·Ñ¤Î¤ÑµM®ðµ¥¯à·½¡C¬°½T«O¯à·½¨ÑÀ³Ã­©w¡A¤£·|¦]»ù®æ¤Wº¦©Î¨ä¥L¦]¯À¦Ó¥X²{µu¯Ê¡A³y¦¨¯à·½¦M¾÷¡A°ê»Ú¯à·½¸p¡]... ¸Ô±¡
¹Ï¬ÝijÃD¡G¥ß·|·s¿ï¨î
¡i©ú³ø±M°T¡j§ï¨î«áªº¥ßªk·|¿ïÁ|±N©ó2021¦~12¤ë19¤éÁ|¦æ¡A·s¤@©¡¥ßªk·|·|´Á©ó2022¦~1¤ë1¤é¶}©l¡C ¡D¥D­n¬ÛÃö½ÒÃD¡G¡u¤@°ê¨â¨î¡v... ¸Ô±¡
µJÂI·s»D¡G±i®a¬É¤¸¦t©z¬ã¨s¤¤¤ß  ºÙ±À¶i¼Æ¦r¤Æ®È¹C
¡i©ú³ø±M°T¡j¡½¡]§ï­²¶}©ñ¥H¨Óªº°ê®a¡^ ´ò«n¡u±i®a¬É¤¸¦t©z¬ã¨s¤¤¤ß¡v11¤ë18¤é¦bªZ³®·½°Ï¤j¼Æ¾Ú¤¤¤ß¥¿¦¡¦¨¥ß¡A±i®a¬É¥ç¦¨¬°¥þ°ê­º­Ó³]¥ß¤¸... ¸Ô±¡
·s»D¸Ñ½X¡G©ç½æ·R¦]´µ©Z¤â½Z
¡i©ú³ø±M°T¡j§Ú­Ì¥­¤éÁʪ«¡A¥u»Ý«ö©w»ù¥I´Ú¡C¦Ü©ó¿W¤@µL¤Gªº¡B¨ã»ù­Èªº¬ÃÂáA·|©ó©ç½æ¦æ©ç½æ¡A»ù°ªªÌ±o¡CµÛ¦Wª«²z¾Ç®a·R¦]´µ©Z¦³Ãö¼s¸q¬Û¹ï½×ªº¤â½Z¡A... ¸Ô±¡

©ú³øºô¯¸ ¡P ª©Åv©Ò¦³ ¡P ¤£±oÂà¸ü
Copyright © 2021 mingpaocanada.com All rights reserved.
Ming Pao Daily News A wholly owned subsidiary of Ming Pao Enterprise Corporation Ltd.
Toronto Chinese Newspaper

Chief Executive Officer: Ka Ming Lui | Executive Chief Editor: Richard Kwok Kai Ng
1355 Huntingwood Drive, Scarborough, Ontario, Canada M1S 3J1 | Tel.: (416) 321-0088 | Fax: (416) 321-5377 | Advertising Hotline Tel: (416) 673-8250